Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $359

Benzinga · 2d ago
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $337 to $359.